Citations

Clear

2960 citation(s) found for "Kim, P".

Clinical and Pharmacological Studies on Liver Disease Treated with Kampo Herbal Medicine
Cyong, Jong‐Chol, Kim, Sunmin , Iijima, Koji, Furuya, Minoru, Kobayashi, Takao

Mayo Clinic

The American Journal of Chinese Medicine | November 5, 2003 | Volume: 28 | Issue: 03n04 | Pages: 351-360

10.1142/s0192415x00000416 | PMID 11154048 Get It

Hepatitis C virus (HCV) infection frequently causes chronic hepatitis, which is linked to the development of liver cirrhosis and hepatocellular carcinoma. Most physicians who practice Kampo medicine in Japan have observed that Kampo medicine can be as effective as interferon therapy in the treatment of chronic hepatitis C. In the present study, to evaluate the effect of Kampo medicine on chronic hepatitis C, clinical treatment was assessed in short-term and long-term study, and it was shown that Ninjin-yoei-to (Formula ginseng compositae: TJ-108 was very effective. Therefore, to find the most active herbal component of TJ-108, in the treatment of HCV, Citrus Unshiu Peel, Schisandra Fruit, and Polygala Root, which are specific to TJ-108, were screened using an in vitro HCV infection model. Among the three herbs, Schisandra Fruit was found to be most active. In the next step, Gomisin A, an active component of Schisandra Fruit, was studied using an in vitro model with MOLT-4 cells and an animnal model of immunologically induced acute hepatic failures. It is concluded that the therapeutic effect of TJ-108 on chronic hepatitis C is from the inhibitory effect on HCV infection, and also from the protective effect on immunological hepatopathy of Schisandra Fruit and its lignan component, Gomisin A.
Identification of genes modulated in multiple myeloma using genetically identical twin samples
Munshi, Nikhil C. , Hideshima, Teru , Carrasco, Daniel E. , Shammas, Masood A. , Auclair, Daniel , Davies, Faith E. , Mitsiades, Nicholas , Mitsiades, Constantine S. , Kim, Ryung Suk, Rajkumar, S. Vincent , Fonseca, Rafaël , Bergsagel, Lief, Chauhan, Dharminder , Bergsagel, P. Leif , Li, Cheng , Anderson, Kenneth C. , Bergsagel, P. Leif , Rajkumar, S Vincent , Davies, Faith E , Fonseca, Rafael

Mayo Clinic

Blood | September 16, 2003 | Volume: 103 | Issue: 5 | Pages: 1799-1806

10.1182/blood-2003-02-0402 | PMID 12969976 Get It

AbstractGenetic heterogeneity between individuals confounds the comparison of gene profiling of multiple myeloma (MM) cells versus normal plasma cells (PCs). To overcome this barrier, we compared the gene expression profile of CD138+ MM cells from a patient bone marrow (BM) sample with CD138+ PCs from a genetically identical twin BM sample using microarray profiling. Two hundred and ninety-six genes were up-regulated and 103 genes were down-regulated at least 2-fold in MM cells versus normal twin PCs. Highly expressed genes in MM cells included cell survival pathway genes such as mcl-1, dad-1, caspase 8, and FADD-like apoptosis regulator (FLIP); oncogenes/transcriptional factors such as Jun-D, Xbp-1, calmodulin, Calnexin, and FGFR-3; stress response and ubiquitin/proteasome pathway–related genes and various ribosomal genes reflecting increased metabolic and translational activity. Genes that were down-regulated in MM cells versus healthy twin PCs included RAD51, killer cell immunoglobulin-like receptor protein, and apoptotic protease activating factor. Microarray results were further confirmed by Western blot analyses, immunohistochemistry, fluorescent in situ hybridization (FISH), and functional assays of telomerase activity and bone marrow angiogenesis. This molecular profiling provides potential insights into mechanisms of malignant transformation in MM. For example, FGFR3, xbp-1, and both mcl-1 and dad-1 may mediate transformation, differentiation, and survival, respectively, and may have clinical implications. By identifying genes uniquely altered in MM cells compared with normal PCs in an identical genotypic background, the current study provides the framework to identify novel therapeutic targets.
IN VITRO SIMULATION OF THE STANCE PHASE IN HUMAN GAIT
Kim, Kyu-Jung, Kitaoka, Harold B. , Luo, Zong‐Ping , Ozeki, Satoru , Berglund, Lawrence J., An, Kai‐Nan, Kaufman, Kenton R.

Mayo Clinic

Journal of Musculoskeletal Research | April 22, 2003 | Volume: 05 | Issue: 02 | Pages: 113-121

10.1142/s0218957701000490 Get It

The purpose of this study is to develop an electromechanical system for dynamic simulation of the stance phase of a human gait using cadaveric foot specimens. The system can be used for quantification of foot and ankle pathomechanics and design of foot and ankle reconstructive surgeries. Servo-pneumatic systems were used for application of the tibial weight loading and muscle loadings. A four-bar mechanism was constructed to provide the progressive motion of a tibia during the simulation while the external loadings were simultaneously applied. Muscle loadings were estimated based on the physiological cross-sectional area and normal electromyography (EMG) data with the assumption of the linear EMG–force relationship. Ad hoc tuning of the unknown muscle gains was conducted until a reasonable match with the normal vertical ground reaction force profile, center of pressure advancement, and characteristic foot motion events (heel strike, foot flat, heel rise and toe-off) could be made. Three cadaver feet and an artificial foot were tested with five repeated trials. The simulator reproduced the stance phase of a human gait in the sagittal plane with reasonable accuracy and consistency without compromising either kinematics or kinetics of the foot and ankle complex.
Purification and Characterization of Two Polymorphic Variants of Short Chain Acyl-CoA Dehydrogenase Reveal Reduction of Catalytic Activity and Stability of the Gly185Ser Enzyme
Nguyen, Tien V., Riggs, Charles E., Babovic‐Vuksanovic, Dusica , Kim, Yong‐Sung , Carpenter, John F. , Gregersen, Niels , Vockley, Jerry , Nguyen, Tien V., Burghardt, Thomas P.

Mayo Clinic

Biochemistry | September 10, 2002 | Volume: 41 | Issue: 37 | Pages: 11126-11133

10.1021/bi026030r | PMID 12220177 Get It

Chronobiological Patterns of Acute Aortic Dissection
Mehta, Rajendra H. , Manfredini, Roberto , Hassan, Fauziya, Sechtem, Udo , Bossone, Eduardo , Oh, Jae K. , Cooper, Jeanna V., Smith, Dean E., Portaluppi, Francesco , Penn, Marc S. , Hutchison, Stuart J., Nienaber, Christoph , Isselbacher, Eric M. , Eagle, Kim A. , Bossone, Eduardo

Mayo Clinic

Circulation | August 27, 2002 | Volume: 106 | Issue: 9 | Pages: 1110-1115

10.1161/01.cir.0000027568.39540.4b | PMID 12196337 Get It

Background— Chronobiological rhythms have been shown to influence the occurrence of a variety of cardiovascular disorders. However, the effects of the time of the day, the day of the week, or monthly/seasonal changes on acute aortic dissection (AAD) have not been well studied. Methods and Results— Accordingly, we evaluated 957 patients enrolled in the International Registry of Acute Aortic Dissection (IRAD) between 1996 and 2000 (mean age 62±14 years, type A 61%). A χ 2 test for goodness of fit and partial Fourier analysis were used to evaluate nonuniformity and rhythmicity of AAD during circadian, weekly, and monthly periods. A significantly higher frequency of AAD occurred from 6:00 am to 12:00 noon compared with other time periods (12:00 noon to 6:00 pm , 6:00 pm to 12:00 midnight, and 12:00 midnight to 6:00 am ; P <0.001 by χ 2 test). Fourier analysis showed a highly significant circadian variation ( P <0.001) with a peak between 8:00 am and 9:00 am . Although no significant variation was found for the day of the week, the frequency of AAD was significantly higher during winter ( P =0.008 versus other seasons by χ 2 test). Fourier analysis confirmed this monthly variation with a peak in January ( P <0.001). Subgroup analysis identified a significant association for all subgroups with circadian rhythmicity. However, seasonal/monthly variations were observed only among patients aged <70 years, those with type B AAD, and those without hypertension or diabetes. Conclusions— Similar to other cardiovascular conditions, AAD exhibits significant circadian and seasonal/monthly variations. Our findings may have important implications for the prevention of AAD by tailoring treatment strategies to ensure maximal benefits during the vulnerable periods.
Regulated Interactions between Dynamin and the Actin-Binding Protein Cortactin Modulate Cell Shape
McNiven, Mark A. , Kim, Leung, Krueger, Eugene W. , Orth, James D. , Cao, Hong , Wong, Tai W.

Mayo Clinic

The Journal of Cell Biology | July 26, 2002 | Volume: 151 | Issue: 1 | Pages: 187-198

10.1083/jcb.151.1.187 | PMID 11018064 Get It

The dynamin family of large GTPases has been implicated in the formation of nascent vesicles in both the endocytic and secretory pathways. It is believed that dynamin interacts with a variety of cellular proteins to constrict membranes. The actin cytoskeleton has also been implicated in altering membrane shape and form during cell migration, endocytosis, and secretion and has been postulated to work synergistically with dynamin and coat proteins in several of these important processes. We have observed that the cytoplasmic distribution of dynamin changes dramatically in fibroblasts that have been stimulated to undergo migration with a motagen/hormone. In quiescent cells, dynamin 2 (Dyn 2) associates predominantly with clathrin-coated vesicles at the plasma membrane and the Golgi apparatus. Upon treatment with PDGF to induce cell migration, dynamin becomes markedly associated with membrane ruffles and lamellipodia. Biochemical and morphological studies using antibodies and GFP-tagged dynamin demonstrate an interaction with cortactin. Cortactin is an actin-binding protein that contains a well defined SH3 domain. Using a variety of biochemical methods we demonstrate that the cortactin–SH3 domain associates with the proline-rich domain (PRD) of dynamin. Functional studies that express wild-type and mutant forms of dynamin and/or cortactin in living cells support these in vitro observations and demonstrate that an increased expression of cortactin leads to a significant recruitment of endogenous or expressed dynamin into the cell ruffle. Further, expression of a cortactin protein lacking the interactive SH3 domain (CortΔSH3) significantly reduces dynamin localization to the ruffle. Accordingly, transfected cells expressing Dyn 2 lacking the PRD (Dyn 2(aa)ΔPRD) sequester little of this protein to the cortactin-rich ruffle. Interestingly, these mutant cells are viable, but display dramatic alterations in morphology. This change in shape appears to be due, in part, to a striking increase in the number of actin stress fibers. These findings provide the first demonstration that dynamin can interact with the actin cytoskeleton to regulate actin reorganization and subsequently cell shape.
A Functional Link between Dynamin and the Actin Cytoskeleton at Podosomes
Ochoa, Gian-Carlo, Slepnev, Vladimir I., Neff, Lynn, Ringstad, Niels , Takei, Kohji , Daniell, Laurie, Kim, Warren, Cao, Hong , McNiven, Mark A. , Baron, Roland , Camilli, Pietro De

Mayo Clinic

The Journal of Cell Biology | July 26, 2002 | Volume: 150 | Issue: 2 | Pages: 377-390

10.1083/jcb.150.2.377 | PMID 10908579 Get It

Cell transformation by Rous sarcoma virus results in a dramatic change of adhesion structures with the substratum. Adhesion plaques are replaced by dot-like attachment sites called podosomes. Podosomes are also found constitutively in motile nontransformed cells such as leukocytes, macrophages, and osteoclasts. They are represented by columnar arrays of actin which are perpendicular to the substratum and contain tubular invaginations of the plasma membrane. Given the similarity of these tubules to those generated by dynamin around a variety of membrane templates, we investigated whether dynamin is present at podosomes. Immunoreactivities for dynamin 2 and for the dynamin 2–binding protein endophilin 2 (SH3P8) were detected at podosomes of transformed cells and osteoclasts. Furthermore, GFP wild-type dynamin 2aa was targeted to podosomes. As shown by fluorescence recovery after photobleaching, GFP-dynamin 2aa and GFP-actin had a very rapid and similar turnover at podosomes. Expression of the GFP-dynamin 2aaG273D abolished podosomes while GFP-dynaminK44A was targeted to podosomes but delayed actin turnover. These data demonstrate a functional link between a member of the dynamin family and actin at attachment sites between cells and the substratum.
Growth of β-Amyloid(1−40) Protofibrils by Monomer Elongation and Lateral Association. Characterization of Distinct Products by Light Scattering and Atomic Force Microscopy
Nichols, Michael R. , Moss, Melissa A. , Reed, Dana Kim , Lin, Wen-Lang, Mukhopadhyay, Rajendrani, Hoh, Jan H. , Rosenberry, Terrone L.

Mayo Clinic

Biochemistry | July 26, 2002 | Volume: 41 | Issue: 19 | Pages: 6115-6127

10.1021/bi015985r | PMID 11994007 Get It

Characterization of Molecular Defects in Isovaleryl-CoA Dehydrogenase in Patients with Isovaleric Acidemia
Mohsen, Al‐Walid , Anderson, Bambi D., Volchenboum, Samuel L. , Battaile, K.P. , Tiffany, Karen, Kim, Jung‐Ja P. , Vockley, Jerry , Roberts, David D.

Mayo Clinic

Biochemistry | July 26, 2002 | Volume: 37 | Issue: 28 | Pages: 10325-10335

10.1021/bi973096r | PMID 9665741 Get It

Structure of Human Isovaleryl-CoA Dehydrogenase at 2.6 Å Resolution:  Structural Basis for Substrate Specificity,
Tiffany, Karen, Roberts, David L., Paschke, Rosemary, Mohsen, Al‐Walid , Vockley, Jerry , Kim, Jung‐Ja P. , Roberts, David Leland , Wang, Ming

Mayo Clinic

Biochemistry | July 26, 2002 | Volume: 36 | Issue: 28 | Pages: 8455-8464

10.1021/bi970422u | PMID 9214289 Get It